Canada · Delayed Price · Currency is CAD Quantum BioPharma Statistics
Total Valuation
CSE:QNTM has a market cap or net worth of CAD 64.89 million. The enterprise value is 63.55 million.
| Market Cap | 64.89M |
| Enterprise Value | 63.55M |
Important Dates
The next estimated earnings date is Thursday, November 6, 2025.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:QNTM has 3.82 million shares outstanding. The number of shares has increased by 254.05% in one year.
| Current Share Class | 3.82M |
| Shares Outstanding | 3.82M |
| Shares Change (YoY) | +254.05% |
| Shares Change (QoQ) | +22.06% |
| Owned by Insiders (%) | 8.59% |
| Owned by Institutions (%) | 24.94% |
| Float | 3.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 23.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.72 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.11.
| Current Ratio | 0.78 |
| Quick Ratio | 0.36 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -123.36 |
Financial Efficiency
Return on equity (ROE) is -456.81% and return on invested capital (ROIC) is -154.18%.
| Return on Equity (ROE) | -456.81% |
| Return on Assets (ROA) | -76.42% |
| Return on Invested Capital (ROIC) | -154.18% |
| Return on Capital Employed (ROCE) | -912.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.17M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +135.90% in the last 52 weeks. The beta is 0.76, so CSE:QNTM's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +135.90% |
| 50-Day Moving Average | 22.38 |
| 200-Day Moving Average | 18.45 |
| Relative Strength Index (RSI) | 34.01 |
| Average Volume (20 Days) | 3,765 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.47M |
| Pretax Income | -38.16M |
| Net Income | -36.85M |
| EBITDA | -24.78M |
| EBIT | -25.47M |
| Earnings Per Share (EPS) | -16.79 |
Balance Sheet
The company has 2.08 million in cash and 3.09 million in debt, giving a net cash position of -1.00 million or -0.26 per share.
| Cash & Cash Equivalents | 2.08M |
| Total Debt | 3.09M |
| Net Cash | -1.00M |
| Net Cash Per Share | -0.26 |
| Equity (Book Value) | 2.79M |
| Book Value Per Share | 1.48 |
| Working Capital | -3.96M |
Cash Flow
| Operating Cash Flow | -14.33M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:QNTM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -254.05% |
| Shareholder Yield | -254.05% |
| Earnings Yield | -56.79% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 15, 2024. It was a reverse split with a ratio of 0.0153846154.
| Last Split Date | Aug 15, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0153846154 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |